Early Cancer Detection Test
Early Cancer Detection Test
Couldn't load pickup availability
Here at Dynamic, we're proud to announce our first early cancer detection test! This test, also known as EPISEEK, is a liquid biopsy test and is able to detect circulating tumor DNA from more than 20 common cancer types as a part of a comprehensive ancology workup!
Which cancers can EPISEEK detect?
- Lung
- Breast
- Prostate
- Colorectal
- Pancreatic
- Head and Neck
- Urinary Bladder
- Esophageal
*The EPISEEK liquid biopsy test is intended to be used as a complimentary tool to established cancer screening assessments

So what is EPISEEK and how does it work?
The Precision Epigenomics Liquid Biopsy Test, EPISEEK, is a blood-based test designed to detect circulating tumor DNA (ctDNA) from a simple blood draw. EPISEEK analyzes epigenomic modifications present on the ctDNA. Special software is used to analyze the results and aids the pathologist to issue a report that specifies if an abnormal signal is detected or if no cancer signal is detected.
*PLEASE NOTE
This sample must be recieved by our lab within 48 hours of collection.